CPHI News and Press, China Pharma Holdings Inc. From 11/29/23

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device PR Newswire HAIKOU, China , Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company...

2023-08-21 07:25:57 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time to start the week with a look at the biggest pre-market stock movers worth watching on Monday! Moving stocks this morning are a share transfer, stock offering, earnings dat...

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs PR Newswire HAIKOU, China , Aug. 9, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "W...

China Pharma ( NYSE: CPHI ) on Friday said it expects to implement a 1-for-10 reverse stock split on its common stock. Trading to begin on a split-adjusted basis at market open on March 6, 2023. Trading in the common stock will continue on the NYSE American under...

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split PR Newswire HAIKOU, China , Feb. 24, 2023 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-f...

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask PR Newswire HAIKOU, China , Dec. 28, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corpor...

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 PR Newswire HAIKOU, China , Dec. 15, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma...

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project PR Newswire HAIKOU, China , Dec. 5, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE Ame...

China Pharma ( NYSE: CPHI ) received a deficiency letter from NYSE stating that the company's common stock has been selling for a low price per share for a substantial period of time. Most recently, the average price of the company's common stock had been below $0.20 on a ...

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency PR Newswire HAIKOU, China , Oct. 1, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI; the "Company") today announced that on September 26, 2022 ...